» Articles » PMID: 26606981

Evidence That HIV-1 Restriction Factor SAMHD1 Facilitates Differentiation of Myeloid THP-1 Cells

Overview
Journal Virol J
Publisher Biomed Central
Specialty Microbiology
Date 2015 Nov 27
PMID 26606981
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: SAMHD1 counteracts HIV-1 or HIV-2/SIVsmm that lacks Vpx by depleting the intracellular pool of nucleotides in myeloid cells and CD4+ quiescent T cells, thereby inhibiting the synthesis of retroviral DNA by reverse transcriptase. Depletion of nucleotides has been shown to underline the establishment of quiescence in certain cellular systems. These observations led us to investigate whether SAMHD1 could control the transition between proliferation and quiescence using the THP-1 cell model.

Findings: The entry of dividing THP-1 myeloid cells into a non-dividing differentiated state was monitored after addition of phorbol-12-myristate-13-acetate (PMA), an inducer of differentiation. Under PMA treatment, cells overexpressing SAMHD1 display stronger and faster adhesion to their support, compared to cells expressing a catalytically inactive form of SAMHD1, or cells depleted of SAMHD1, which appear less differentiated. After PMA removal, cells overexpressing SAMHD1 maintain low levels of cyclin A, in contrast to other cell lines. Interestingly, SAMHD1 overexpression slightly increases cell adhesion even in the absence of the differentiation inducer PMA. Finally, we found that levels of SAMHD1 are reduced in proliferating primary CD4+ T cells after T cell receptor activation, suggesting that SAMHD1 may also be involved in the transition from a quiescent state to a dividing state in primary T cells.

Conclusions: Altogether, we provide evidence that SAMHD1 may facilitate some aspects of THP-1 cell differentiation. Restriction of HIV-1 by SAMHD1 may rely upon its ability to modify cell cycle parameters, in addition to the direct inhibition of reverse transcription.

Citing Articles

SAMHD1 Functions and Human Diseases.

Coggins S, Mahboubi B, Schinazi R, Kim B Viruses. 2020; 12(4).

PMID: 32244340 PMC: 7232136. DOI: 10.3390/v12040382.


SAMHD1: Recurring roles in cell cycle, viral restriction, cancer, and innate immunity.

Mauney C, Hollis T Autoimmunity. 2018; 51(3):96-110.

PMID: 29583030 PMC: 6117824. DOI: 10.1080/08916934.2018.1454912.

References
1.
Baldauf H, Pan X, Erikson E, Schmidt S, Daddacha W, Burggraf M . SAMHD1 restricts HIV-1 infection in resting CD4(+) T cells. Nat Med. 2012; 18(11):1682-7. PMC: 3828732. DOI: 10.1038/nm.2964. View

2.
Cribier A, Descours B, Chaves Valadao A, Laguette N, Benkirane M . Phosphorylation of SAMHD1 by cyclin A2/CDK1 regulates its restriction activity toward HIV-1. Cell Rep. 2013; 3(4):1036-43. DOI: 10.1016/j.celrep.2013.03.017. View

3.
Munoz-Pacheco P, Ortega-Hernandez A, Miana M, Cachofeiro V, Fernandez-Cruz A, Gomez-Garre D . Ezetimibe inhibits PMA-induced monocyte/macrophage differentiation by altering microRNA expression: a novel anti-atherosclerotic mechanism. Pharmacol Res. 2012; 66(6):536-43. DOI: 10.1016/j.phrs.2012.09.005. View

4.
Landau D, Carter S, Stojanov P, McKenna A, Stevenson K, Lawrence M . Evolution and impact of subclonal mutations in chronic lymphocytic leukemia. Cell. 2013; 152(4):714-26. PMC: 3575604. DOI: 10.1016/j.cell.2013.01.019. View

5.
Dragin L, Nguyen L, Lahouassa H, Sourisce A, Kim B, Ramirez B . Interferon block to HIV-1 transduction in macrophages despite SAMHD1 degradation and high deoxynucleoside triphosphates supply. Retrovirology. 2013; 10:30. PMC: 3599726. DOI: 10.1186/1742-4690-10-30. View